Healthcare provider profile · identity verified

Micah Schmal, DO

Family Practice · HAMILTON, OH · NPI 1861923575

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	597	162
Levothyroxine Sodium	Levothyroxine Sodium	367	94
Lisinopril	Lisinopril	300	92
Amlodipine Besylate	Amlodipine Besylate	294	79
Metformin Hcl	Metformin Hcl	209	59
Losartan Potassium	Losartan Potassium	192	47
Gabapentin	Gabapentin	180	52
Pantoprazole Sodium	Pantoprazole Sodium	158	52
Metoprolol Succinate	Metoprolol Succinate	132	37
Pravastatin Sodium	Pravastatin Sodium	131	32
Rosuvastatin Calcium	Rosuvastatin Calcium	131	38
Trulicity	Dulaglutide	127	21
Hydrochlorothiazide	Hydrochlorothiazide	124	40
Duloxetine Hcl	Duloxetine Hcl	118	35
Trazodone Hcl	Trazodone Hcl	118	37
Montelukast Sodium	Montelukast Sodium	111	37
Sertraline Hcl	Sertraline Hcl	111	19
Alendronate Sodium	Alendronate Sodium	100	35
Omeprazole	Omeprazole	100	29
Albuterol Sulfate Hfa	Albuterol Sulfate	98	41
Escitalopram Oxalate	Escitalopram Oxalate	92	28
Famotidine	Famotidine	89	26
Tamsulosin Hcl	Tamsulosin Hcl	86	29
Furosemide	Furosemide	85	34
Jardiance	Empagliflozin	84	23
Ozempic	Semaglutide	81	18
Metformin Hcl Er	Metformin Hcl	80	22
Simvastatin	Simvastatin	80	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	75	18
Ezetimibe	Ezetimibe	69	22
Farxiga	Dapagliflozin Propanediol	59	15
Metoprolol Tartrate	Metoprolol Tartrate	59	20
Tizanidine Hcl	Tizanidine Hcl	59	16
Bupropion Xl	Bupropion Hcl	55	16
Fluticasone Propionate	Fluticasone Propionate	55	18
Tramadol Hcl	Tramadol Hcl	55	13
Clopidogrel	Clopidogrel Bisulfate	50	14
Atenolol	Atenolol	48	13
Mounjaro	Tirzepatide	48	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	15
Potassium Chloride	Potassium Chloride	46	19
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	14
Diclofenac Sodium	Diclofenac Sodium	40	19
Synthroid	Levothyroxine Sodium	40	13
Allopurinol	Allopurinol	39	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Ondansetron Odt	Ondansetron	39	16
Spironolactone	Spironolactone	39	16
Glimepiride	Glimepiride	38	11
Citalopram Hbr	Citalopram Hydrobromide	37	suppressed
Diazepam	Diazepam	37	suppressed
Finasteride	Finasteride	35	11
Paroxetine Hcl	Paroxetine Hcl	34	suppressed
Meloxicam	Meloxicam	33	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Valsartan	Valsartan	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Baclofen	Baclofen	31	suppressed
Carvedilol	Carvedilol	31	11
Eliquis	Apixaban	30	suppressed
Celecoxib	Celecoxib	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Lorazepam	Lorazepam	27	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Prednisone	Prednisone	24	21
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	23	suppressed
Pregabalin	Pregabalin	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Xarelto	Rivaroxaban	20	suppressed
Aripiprazole	Aripiprazole	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Fenofibrate	Fenofibrate,micronized	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Nifedipine Er	Nifedipine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Azithromycin	Azithromycin	16	16
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Gemtesa	Vibegron	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Naproxen	Naproxen	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Benazepril Hcl	Benazepril Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	13
Droplet Pen Needle	Pen Needle, Diabetic	13	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Indapamide	Indapamide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Memantine Hcl Er	Memantine Hcl	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error